Global Pharma Excipients

Pharma Excipients Comprehensive Study by Type (Organic Chemicals (Carbohyrates, Petrochemicals), Inorganic Chemicals (Calcium Phosphates, Calcium Carbonate, Calcium Sulfate, Halites, Metallic Oxides)), Functionality (Tablet, Capsule, Topical, Parenteral), Formulation (Oral Formulations, Topical Formulations, Parenteral Formulations, Other Formulations) Players and Region - Global Market Outlook to 2026

Pharma Excipients Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Pharma Excipients Market Scope?
Pharmaceutical excipients are substances other than the pharmacologically active drug or prodrug which are included in the manufacturing process or are contained in a finished pharmaceutical product dosage form. The growing pharmaceutical industry and rising adoption of orphan drugs are driving the market for pharmaceutical excipients. Increasing uptake of biopharmaceuticals trending in the market.

The Pharma Excipients market study is being classified by Type (Organic Chemicals (Carbohyrates, Petrochemicals) and Inorganic Chemicals (Calcium Phosphates, Calcium Carbonate, Calcium Sulfate, Halites, Metallic Oxides)) and major geographies with country level break-up.

Analysts at AMA predicts that Players from United States will contribute to the maximum growth of Global Pharma Excipients market throughout the predicted period.

DuPont de Nemours, Inc. (United States), Roquette Feres (France), Ashland Global Holdings, Inc. (United States), BASF SE (Germany), Evonik Industries AG (Germany), Associated British Foods plc (United Kingdom), Archer Daniels Midland Company (United States), Lubrizol Corporation (United States), Croda International (United Kingdom) and Innophos Holdings (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Kerry Group plc (Ireland), WACKER Chemie AG (Germany), Colorcon, Inc. (United States), DFE Pharma (Germany), JRS Pharma (Germany) and Air Liquide (France).

Segmentation Analysis
Analyst at AMA have segmented the market study of Global Pharma Excipients market by Type, Application and Region.

On the basis of geography, the market of Pharma Excipients has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

Market Influencers and their development strategies
In January 2019, Croda International (UK) acquired Brenntag Biosector (Denmark) for its vaccine adjuvants portfolio which would be complementary to Croda’s pharmaceutical excipients portfolio.
In April 2019, Colorcon, Inc. (US) signed an agreement with DuPont Nutrition and Biosciences (US) in order to enhance the current product portfolio of CR Alliance products.


Influencing Market Trend
  • Increasing Uptake of Biopharmaceuticals

Market Drivers
  • Increasing Demand for Medicines due to Various Diseases such as Chronic Dieses
  • Growth in Pharmaceuticals Industry

Opportunities
  • Rising Focus of Pharmaceutical Manufacturing to Emerging Countries
  • Growth in Research and Development Activities for New Product Development

Restraints
  • Higher Production Cost
  • Stringent Government Regulations on Production and Approvemnt for Dugs

Challenges
  • Safety and Quality Concerns


Key Target Audience
Pharma Excipients Provider, End-User Industry, Potential Investors and Research and Development Firm

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.

To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research features not just specific market sizing estimates, but also include significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets , To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.

Report Objectives / Segmentation Covered

By Type
  • Organic Chemicals (Carbohyrates, Petrochemicals)
  • Inorganic Chemicals (Calcium Phosphates, Calcium Carbonate, Calcium Sulfate, Halites, Metallic Oxides)
By Functionality
  • Tablet
  • Capsule
  • Topical
  • Parenteral

By Formulation
  • Oral Formulations
  • Topical Formulations
  • Parenteral Formulations
  • Other Formulations

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Demand for Medicines due to Various Diseases such as Chronic Dieses
      • 3.2.2. Growth in Pharmaceuticals Industry
    • 3.3. Market Challenges
      • 3.3.1. Safety and Quality Concerns
    • 3.4. Market Trends
      • 3.4.1. Increasing Uptake of Biopharmaceuticals
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Pharma Excipients, by Type, Functionality, Formulation and Region (value and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Pharma Excipients (Value)
      • 5.2.1. Global Pharma Excipients by: Type (Value)
        • 5.2.1.1. Organic Chemicals (Carbohyrates, Petrochemicals)
        • 5.2.1.2. Inorganic Chemicals (Calcium Phosphates, Calcium Carbonate, Calcium Sulfate, Halites, Metallic Oxides)
      • 5.2.2. Global Pharma Excipients by: Functionality (Value)
        • 5.2.2.1. Tablet
        • 5.2.2.2. Capsule
        • 5.2.2.3. Topical
        • 5.2.2.4. Parenteral
      • 5.2.3. Global Pharma Excipients by: Formulation (Value)
        • 5.2.3.1. Oral Formulations
        • 5.2.3.2. Topical Formulations
        • 5.2.3.3. Parenteral Formulations
        • 5.2.3.4. Other Formulations
      • 5.2.4. Global Pharma Excipients Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Pharma Excipients (Price)
      • 5.3.1. Global Pharma Excipients by: Type (Price)
  • 6. Pharma Excipients: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. DuPont de Nemours, Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Roquette Feres (France)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Ashland Global Holdings, Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. BASF SE (Germany)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Evonik Industries AG (Germany)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Associated British Foods plc (United Kingdom)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Archer Daniels Midland Company (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Lubrizol Corporation (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Croda International (United Kingdom)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Innophos Holdings (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Pharma Excipients Sale, by Type, Functionality, Formulation and Region (value and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Pharma Excipients (Value)
      • 7.2.1. Global Pharma Excipients by: Type (Value)
        • 7.2.1.1. Organic Chemicals (Carbohyrates, Petrochemicals)
        • 7.2.1.2. Inorganic Chemicals (Calcium Phosphates, Calcium Carbonate, Calcium Sulfate, Halites, Metallic Oxides)
      • 7.2.2. Global Pharma Excipients by: Functionality (Value)
        • 7.2.2.1. Tablet
        • 7.2.2.2. Capsule
        • 7.2.2.3. Topical
        • 7.2.2.4. Parenteral
      • 7.2.3. Global Pharma Excipients by: Formulation (Value)
        • 7.2.3.1. Oral Formulations
        • 7.2.3.2. Topical Formulations
        • 7.2.3.3. Parenteral Formulations
        • 7.2.3.4. Other Formulations
      • 7.2.4. Global Pharma Excipients Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Pharma Excipients (Price)
      • 7.3.1. Global Pharma Excipients by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Pharma Excipients: by Type(USD Million)
  • Table 2. Pharma Excipients Organic Chemicals (Carbohyrates, Petrochemicals) , by Region USD Million (2015-2020)
  • Table 3. Pharma Excipients Inorganic Chemicals (Calcium Phosphates, Calcium Carbonate, Calcium Sulfate, Halites, Metallic Oxides) , by Region USD Million (2015-2020)
  • Table 4. Pharma Excipients: by Functionality(USD Million)
  • Table 5. Pharma Excipients Tablet , by Region USD Million (2015-2020)
  • Table 6. Pharma Excipients Capsule , by Region USD Million (2015-2020)
  • Table 7. Pharma Excipients Topical , by Region USD Million (2015-2020)
  • Table 8. Pharma Excipients Parenteral , by Region USD Million (2015-2020)
  • Table 9. Pharma Excipients: by Formulation(USD Million)
  • Table 10. Pharma Excipients Oral Formulations , by Region USD Million (2015-2020)
  • Table 11. Pharma Excipients Topical Formulations , by Region USD Million (2015-2020)
  • Table 12. Pharma Excipients Parenteral Formulations , by Region USD Million (2015-2020)
  • Table 13. Pharma Excipients Other Formulations , by Region USD Million (2015-2020)
  • Table 14. South America Pharma Excipients, by Country USD Million (2015-2020)
  • Table 15. South America Pharma Excipients, by Type USD Million (2015-2020)
  • Table 16. South America Pharma Excipients, by Functionality USD Million (2015-2020)
  • Table 17. South America Pharma Excipients, by Formulation USD Million (2015-2020)
  • Table 18. Brazil Pharma Excipients, by Type USD Million (2015-2020)
  • Table 19. Brazil Pharma Excipients, by Functionality USD Million (2015-2020)
  • Table 20. Brazil Pharma Excipients, by Formulation USD Million (2015-2020)
  • Table 21. Argentina Pharma Excipients, by Type USD Million (2015-2020)
  • Table 22. Argentina Pharma Excipients, by Functionality USD Million (2015-2020)
  • Table 23. Argentina Pharma Excipients, by Formulation USD Million (2015-2020)
  • Table 24. Rest of South America Pharma Excipients, by Type USD Million (2015-2020)
  • Table 25. Rest of South America Pharma Excipients, by Functionality USD Million (2015-2020)
  • Table 26. Rest of South America Pharma Excipients, by Formulation USD Million (2015-2020)
  • Table 27. Asia Pacific Pharma Excipients, by Country USD Million (2015-2020)
  • Table 28. Asia Pacific Pharma Excipients, by Type USD Million (2015-2020)
  • Table 29. Asia Pacific Pharma Excipients, by Functionality USD Million (2015-2020)
  • Table 30. Asia Pacific Pharma Excipients, by Formulation USD Million (2015-2020)
  • Table 31. China Pharma Excipients, by Type USD Million (2015-2020)
  • Table 32. China Pharma Excipients, by Functionality USD Million (2015-2020)
  • Table 33. China Pharma Excipients, by Formulation USD Million (2015-2020)
  • Table 34. Japan Pharma Excipients, by Type USD Million (2015-2020)
  • Table 35. Japan Pharma Excipients, by Functionality USD Million (2015-2020)
  • Table 36. Japan Pharma Excipients, by Formulation USD Million (2015-2020)
  • Table 37. India Pharma Excipients, by Type USD Million (2015-2020)
  • Table 38. India Pharma Excipients, by Functionality USD Million (2015-2020)
  • Table 39. India Pharma Excipients, by Formulation USD Million (2015-2020)
  • Table 40. South Korea Pharma Excipients, by Type USD Million (2015-2020)
  • Table 41. South Korea Pharma Excipients, by Functionality USD Million (2015-2020)
  • Table 42. South Korea Pharma Excipients, by Formulation USD Million (2015-2020)
  • Table 43. Taiwan Pharma Excipients, by Type USD Million (2015-2020)
  • Table 44. Taiwan Pharma Excipients, by Functionality USD Million (2015-2020)
  • Table 45. Taiwan Pharma Excipients, by Formulation USD Million (2015-2020)
  • Table 46. Australia Pharma Excipients, by Type USD Million (2015-2020)
  • Table 47. Australia Pharma Excipients, by Functionality USD Million (2015-2020)
  • Table 48. Australia Pharma Excipients, by Formulation USD Million (2015-2020)
  • Table 49. Rest of Asia-Pacific Pharma Excipients, by Type USD Million (2015-2020)
  • Table 50. Rest of Asia-Pacific Pharma Excipients, by Functionality USD Million (2015-2020)
  • Table 51. Rest of Asia-Pacific Pharma Excipients, by Formulation USD Million (2015-2020)
  • Table 52. Europe Pharma Excipients, by Country USD Million (2015-2020)
  • Table 53. Europe Pharma Excipients, by Type USD Million (2015-2020)
  • Table 54. Europe Pharma Excipients, by Functionality USD Million (2015-2020)
  • Table 55. Europe Pharma Excipients, by Formulation USD Million (2015-2020)
  • Table 56. Germany Pharma Excipients, by Type USD Million (2015-2020)
  • Table 57. Germany Pharma Excipients, by Functionality USD Million (2015-2020)
  • Table 58. Germany Pharma Excipients, by Formulation USD Million (2015-2020)
  • Table 59. France Pharma Excipients, by Type USD Million (2015-2020)
  • Table 60. France Pharma Excipients, by Functionality USD Million (2015-2020)
  • Table 61. France Pharma Excipients, by Formulation USD Million (2015-2020)
  • Table 62. Italy Pharma Excipients, by Type USD Million (2015-2020)
  • Table 63. Italy Pharma Excipients, by Functionality USD Million (2015-2020)
  • Table 64. Italy Pharma Excipients, by Formulation USD Million (2015-2020)
  • Table 65. United Kingdom Pharma Excipients, by Type USD Million (2015-2020)
  • Table 66. United Kingdom Pharma Excipients, by Functionality USD Million (2015-2020)
  • Table 67. United Kingdom Pharma Excipients, by Formulation USD Million (2015-2020)
  • Table 68. Netherlands Pharma Excipients, by Type USD Million (2015-2020)
  • Table 69. Netherlands Pharma Excipients, by Functionality USD Million (2015-2020)
  • Table 70. Netherlands Pharma Excipients, by Formulation USD Million (2015-2020)
  • Table 71. Rest of Europe Pharma Excipients, by Type USD Million (2015-2020)
  • Table 72. Rest of Europe Pharma Excipients, by Functionality USD Million (2015-2020)
  • Table 73. Rest of Europe Pharma Excipients, by Formulation USD Million (2015-2020)
  • Table 74. MEA Pharma Excipients, by Country USD Million (2015-2020)
  • Table 75. MEA Pharma Excipients, by Type USD Million (2015-2020)
  • Table 76. MEA Pharma Excipients, by Functionality USD Million (2015-2020)
  • Table 77. MEA Pharma Excipients, by Formulation USD Million (2015-2020)
  • Table 78. Middle East Pharma Excipients, by Type USD Million (2015-2020)
  • Table 79. Middle East Pharma Excipients, by Functionality USD Million (2015-2020)
  • Table 80. Middle East Pharma Excipients, by Formulation USD Million (2015-2020)
  • Table 81. Africa Pharma Excipients, by Type USD Million (2015-2020)
  • Table 82. Africa Pharma Excipients, by Functionality USD Million (2015-2020)
  • Table 83. Africa Pharma Excipients, by Formulation USD Million (2015-2020)
  • Table 84. North America Pharma Excipients, by Country USD Million (2015-2020)
  • Table 85. North America Pharma Excipients, by Type USD Million (2015-2020)
  • Table 86. North America Pharma Excipients, by Functionality USD Million (2015-2020)
  • Table 87. North America Pharma Excipients, by Formulation USD Million (2015-2020)
  • Table 88. United States Pharma Excipients, by Type USD Million (2015-2020)
  • Table 89. United States Pharma Excipients, by Functionality USD Million (2015-2020)
  • Table 90. United States Pharma Excipients, by Formulation USD Million (2015-2020)
  • Table 91. Canada Pharma Excipients, by Type USD Million (2015-2020)
  • Table 92. Canada Pharma Excipients, by Functionality USD Million (2015-2020)
  • Table 93. Canada Pharma Excipients, by Formulation USD Million (2015-2020)
  • Table 94. Mexico Pharma Excipients, by Type USD Million (2015-2020)
  • Table 95. Mexico Pharma Excipients, by Functionality USD Million (2015-2020)
  • Table 96. Mexico Pharma Excipients, by Formulation USD Million (2015-2020)
  • Table 97. Pharma Excipients: by Type(USD/Units)
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Pharma Excipients: by Type(USD Million)
  • Table 109. Pharma Excipients Organic Chemicals (Carbohyrates, Petrochemicals) , by Region USD Million (2021-2026)
  • Table 110. Pharma Excipients Inorganic Chemicals (Calcium Phosphates, Calcium Carbonate, Calcium Sulfate, Halites, Metallic Oxides) , by Region USD Million (2021-2026)
  • Table 111. Pharma Excipients: by Functionality(USD Million)
  • Table 112. Pharma Excipients Tablet , by Region USD Million (2021-2026)
  • Table 113. Pharma Excipients Capsule , by Region USD Million (2021-2026)
  • Table 114. Pharma Excipients Topical , by Region USD Million (2021-2026)
  • Table 115. Pharma Excipients Parenteral , by Region USD Million (2021-2026)
  • Table 116. Pharma Excipients: by Formulation(USD Million)
  • Table 117. Pharma Excipients Oral Formulations , by Region USD Million (2021-2026)
  • Table 118. Pharma Excipients Topical Formulations , by Region USD Million (2021-2026)
  • Table 119. Pharma Excipients Parenteral Formulations , by Region USD Million (2021-2026)
  • Table 120. Pharma Excipients Other Formulations , by Region USD Million (2021-2026)
  • Table 121. South America Pharma Excipients, by Country USD Million (2021-2026)
  • Table 122. South America Pharma Excipients, by Type USD Million (2021-2026)
  • Table 123. South America Pharma Excipients, by Functionality USD Million (2021-2026)
  • Table 124. South America Pharma Excipients, by Formulation USD Million (2021-2026)
  • Table 125. Brazil Pharma Excipients, by Type USD Million (2021-2026)
  • Table 126. Brazil Pharma Excipients, by Functionality USD Million (2021-2026)
  • Table 127. Brazil Pharma Excipients, by Formulation USD Million (2021-2026)
  • Table 128. Argentina Pharma Excipients, by Type USD Million (2021-2026)
  • Table 129. Argentina Pharma Excipients, by Functionality USD Million (2021-2026)
  • Table 130. Argentina Pharma Excipients, by Formulation USD Million (2021-2026)
  • Table 131. Rest of South America Pharma Excipients, by Type USD Million (2021-2026)
  • Table 132. Rest of South America Pharma Excipients, by Functionality USD Million (2021-2026)
  • Table 133. Rest of South America Pharma Excipients, by Formulation USD Million (2021-2026)
  • Table 134. Asia Pacific Pharma Excipients, by Country USD Million (2021-2026)
  • Table 135. Asia Pacific Pharma Excipients, by Type USD Million (2021-2026)
  • Table 136. Asia Pacific Pharma Excipients, by Functionality USD Million (2021-2026)
  • Table 137. Asia Pacific Pharma Excipients, by Formulation USD Million (2021-2026)
  • Table 138. China Pharma Excipients, by Type USD Million (2021-2026)
  • Table 139. China Pharma Excipients, by Functionality USD Million (2021-2026)
  • Table 140. China Pharma Excipients, by Formulation USD Million (2021-2026)
  • Table 141. Japan Pharma Excipients, by Type USD Million (2021-2026)
  • Table 142. Japan Pharma Excipients, by Functionality USD Million (2021-2026)
  • Table 143. Japan Pharma Excipients, by Formulation USD Million (2021-2026)
  • Table 144. India Pharma Excipients, by Type USD Million (2021-2026)
  • Table 145. India Pharma Excipients, by Functionality USD Million (2021-2026)
  • Table 146. India Pharma Excipients, by Formulation USD Million (2021-2026)
  • Table 147. South Korea Pharma Excipients, by Type USD Million (2021-2026)
  • Table 148. South Korea Pharma Excipients, by Functionality USD Million (2021-2026)
  • Table 149. South Korea Pharma Excipients, by Formulation USD Million (2021-2026)
  • Table 150. Taiwan Pharma Excipients, by Type USD Million (2021-2026)
  • Table 151. Taiwan Pharma Excipients, by Functionality USD Million (2021-2026)
  • Table 152. Taiwan Pharma Excipients, by Formulation USD Million (2021-2026)
  • Table 153. Australia Pharma Excipients, by Type USD Million (2021-2026)
  • Table 154. Australia Pharma Excipients, by Functionality USD Million (2021-2026)
  • Table 155. Australia Pharma Excipients, by Formulation USD Million (2021-2026)
  • Table 156. Rest of Asia-Pacific Pharma Excipients, by Type USD Million (2021-2026)
  • Table 157. Rest of Asia-Pacific Pharma Excipients, by Functionality USD Million (2021-2026)
  • Table 158. Rest of Asia-Pacific Pharma Excipients, by Formulation USD Million (2021-2026)
  • Table 159. Europe Pharma Excipients, by Country USD Million (2021-2026)
  • Table 160. Europe Pharma Excipients, by Type USD Million (2021-2026)
  • Table 161. Europe Pharma Excipients, by Functionality USD Million (2021-2026)
  • Table 162. Europe Pharma Excipients, by Formulation USD Million (2021-2026)
  • Table 163. Germany Pharma Excipients, by Type USD Million (2021-2026)
  • Table 164. Germany Pharma Excipients, by Functionality USD Million (2021-2026)
  • Table 165. Germany Pharma Excipients, by Formulation USD Million (2021-2026)
  • Table 166. France Pharma Excipients, by Type USD Million (2021-2026)
  • Table 167. France Pharma Excipients, by Functionality USD Million (2021-2026)
  • Table 168. France Pharma Excipients, by Formulation USD Million (2021-2026)
  • Table 169. Italy Pharma Excipients, by Type USD Million (2021-2026)
  • Table 170. Italy Pharma Excipients, by Functionality USD Million (2021-2026)
  • Table 171. Italy Pharma Excipients, by Formulation USD Million (2021-2026)
  • Table 172. United Kingdom Pharma Excipients, by Type USD Million (2021-2026)
  • Table 173. United Kingdom Pharma Excipients, by Functionality USD Million (2021-2026)
  • Table 174. United Kingdom Pharma Excipients, by Formulation USD Million (2021-2026)
  • Table 175. Netherlands Pharma Excipients, by Type USD Million (2021-2026)
  • Table 176. Netherlands Pharma Excipients, by Functionality USD Million (2021-2026)
  • Table 177. Netherlands Pharma Excipients, by Formulation USD Million (2021-2026)
  • Table 178. Rest of Europe Pharma Excipients, by Type USD Million (2021-2026)
  • Table 179. Rest of Europe Pharma Excipients, by Functionality USD Million (2021-2026)
  • Table 180. Rest of Europe Pharma Excipients, by Formulation USD Million (2021-2026)
  • Table 181. MEA Pharma Excipients, by Country USD Million (2021-2026)
  • Table 182. MEA Pharma Excipients, by Type USD Million (2021-2026)
  • Table 183. MEA Pharma Excipients, by Functionality USD Million (2021-2026)
  • Table 184. MEA Pharma Excipients, by Formulation USD Million (2021-2026)
  • Table 185. Middle East Pharma Excipients, by Type USD Million (2021-2026)
  • Table 186. Middle East Pharma Excipients, by Functionality USD Million (2021-2026)
  • Table 187. Middle East Pharma Excipients, by Formulation USD Million (2021-2026)
  • Table 188. Africa Pharma Excipients, by Type USD Million (2021-2026)
  • Table 189. Africa Pharma Excipients, by Functionality USD Million (2021-2026)
  • Table 190. Africa Pharma Excipients, by Formulation USD Million (2021-2026)
  • Table 191. North America Pharma Excipients, by Country USD Million (2021-2026)
  • Table 192. North America Pharma Excipients, by Type USD Million (2021-2026)
  • Table 193. North America Pharma Excipients, by Functionality USD Million (2021-2026)
  • Table 194. North America Pharma Excipients, by Formulation USD Million (2021-2026)
  • Table 195. United States Pharma Excipients, by Type USD Million (2021-2026)
  • Table 196. United States Pharma Excipients, by Functionality USD Million (2021-2026)
  • Table 197. United States Pharma Excipients, by Formulation USD Million (2021-2026)
  • Table 198. Canada Pharma Excipients, by Type USD Million (2021-2026)
  • Table 199. Canada Pharma Excipients, by Functionality USD Million (2021-2026)
  • Table 200. Canada Pharma Excipients, by Formulation USD Million (2021-2026)
  • Table 201. Mexico Pharma Excipients, by Type USD Million (2021-2026)
  • Table 202. Mexico Pharma Excipients, by Functionality USD Million (2021-2026)
  • Table 203. Mexico Pharma Excipients, by Formulation USD Million (2021-2026)
  • Table 204. Pharma Excipients: by Type(USD/Units)
  • Table 205. Research Programs/Design for This Report
  • Table 206. Key Data Information from Secondary Sources
  • Table 207. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Pharma Excipients: by Type USD Million (2015-2020)
  • Figure 5. Global Pharma Excipients: by Functionality USD Million (2015-2020)
  • Figure 6. Global Pharma Excipients: by Formulation USD Million (2015-2020)
  • Figure 7. South America Pharma Excipients Share (%), by Country
  • Figure 8. Asia Pacific Pharma Excipients Share (%), by Country
  • Figure 9. Europe Pharma Excipients Share (%), by Country
  • Figure 10. MEA Pharma Excipients Share (%), by Country
  • Figure 11. North America Pharma Excipients Share (%), by Country
  • Figure 12. Global Pharma Excipients: by Type USD/Units (2015-2020)
  • Figure 13. Global Pharma Excipients share by Players 2020 (%)
  • Figure 14. Global Pharma Excipients share by Players (Top 3) 2020(%)
  • Figure 15. Global Pharma Excipients share by Players (Top 5) 2020(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. DuPont de Nemours, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 18. DuPont de Nemours, Inc. (United States) Revenue: by Geography 2020
  • Figure 19. Roquette Feres (France) Revenue, Net Income and Gross profit
  • Figure 20. Roquette Feres (France) Revenue: by Geography 2020
  • Figure 21. Ashland Global Holdings, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 22. Ashland Global Holdings, Inc. (United States) Revenue: by Geography 2020
  • Figure 23. BASF SE (Germany) Revenue, Net Income and Gross profit
  • Figure 24. BASF SE (Germany) Revenue: by Geography 2020
  • Figure 25. Evonik Industries AG (Germany) Revenue, Net Income and Gross profit
  • Figure 26. Evonik Industries AG (Germany) Revenue: by Geography 2020
  • Figure 27. Associated British Foods plc (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 28. Associated British Foods plc (United Kingdom) Revenue: by Geography 2020
  • Figure 29. Archer Daniels Midland Company (United States) Revenue, Net Income and Gross profit
  • Figure 30. Archer Daniels Midland Company (United States) Revenue: by Geography 2020
  • Figure 31. Lubrizol Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 32. Lubrizol Corporation (United States) Revenue: by Geography 2020
  • Figure 33. Croda International (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 34. Croda International (United Kingdom) Revenue: by Geography 2020
  • Figure 35. Innophos Holdings (United States) Revenue, Net Income and Gross profit
  • Figure 36. Innophos Holdings (United States) Revenue: by Geography 2020
  • Figure 37. Global Pharma Excipients: by Type USD Million (2021-2026)
  • Figure 38. Global Pharma Excipients: by Functionality USD Million (2021-2026)
  • Figure 39. Global Pharma Excipients: by Formulation USD Million (2021-2026)
  • Figure 40. South America Pharma Excipients Share (%), by Country
  • Figure 41. Asia Pacific Pharma Excipients Share (%), by Country
  • Figure 42. Europe Pharma Excipients Share (%), by Country
  • Figure 43. MEA Pharma Excipients Share (%), by Country
  • Figure 44. North America Pharma Excipients Share (%), by Country
  • Figure 45. Global Pharma Excipients: by Type USD/Units (2021-2026)
List of companies from research coverage that are profiled in the study
  • DuPont de Nemours, Inc. (United States)
  • Roquette Feres (France)
  • Ashland Global Holdings, Inc. (United States)
  • BASF SE (Germany)
  • Evonik Industries AG (Germany)
  • Associated British Foods plc (United Kingdom)
  • Archer Daniels Midland Company (United States)
  • Lubrizol Corporation (United States)
  • Croda International (United Kingdom)
  • Innophos Holdings (United States)
Additional players considered in the study are as follows:
Kerry Group plc (Ireland) , WACKER Chemie AG (Germany) , Colorcon, Inc. (United States) , DFE Pharma (Germany) , JRS Pharma (Germany) , Air Liquide (France)
Select User Access Type

Key Highlights of Report


Dec 2021 226 Pages 96 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Pharma Excipients Quantitative research analysis
Global Pharma Excipients Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Global Pharma Excipients market is expected to see a growth of % during projected year 2020 to 2026.
The prominent players of Global Pharma Excipients market are DuPont de Nemours, Inc. (United States), Roquette Feres (France), Ashland Global Holdings, Inc. (United States), BASF SE (Germany), Evonik Industries AG (Germany), Associated British Foods plc (United Kingdom), Archer Daniels Midland Company (United States), Lubrizol Corporation (United States), Croda International (United Kingdom) and Innophos Holdings (United States), to name a few.
In this highly competitive & fast evolving Pharma Excipients industry, the top strategic priorities would remain consistent like innovation, R&D and M&A.

Know More About Global Pharma Excipients Report?

Have a Query? Click Here

Other Related Reports

Tocotrienol Comprehensive Study by Type (Alpha, Beta, Gamma, Delta), Application (Breast Cancer, Hypertrophic Scars, Fracture Healing, NAFLD, Familial Dysautonomia, Chronic Kidney Disease, Others), D...
$ 3650
Hemostatic Agents Comprehensive Study by Type (Passive Agents (Collagen, Cellulose, Gelatin, Polysaccharide hemospheres), Active Agents (Thrombin, FloSeal, Sealants), Newer Hemostatic Agents (Chitos...
$ 3750
Herbal Medicines Comprehensive Study by Type (Medicinal Part, Medicine Function, Active Ingredient), Application (Western Herbalism, Traditional Chinese Medicine, Others), Sales Channel (Online, Offl...
$ 3500
Albendazole Comprehensive Study by Type (Capsule, Tablet), Application (Flatworms, Nematodes, Giardiasis, Microsporidiosis, Granulomatous Amoebic Encephalitis, Arthropods, Others), Distribution Chann...
$ 3450
Axillary Hyperhidrosis Drug Comprehensive Study by Type (Prescription Antiperspirant, Nerve-blocking Medications, Antidepressants, Botulinum Toxin Injections, Others), Application (Clinic, Hospital, ...
$ 3750
Heparin Calcium Comprehensive Study by Type (Unfractionated Heparin, Low molecular Heparin API), Application (Heart Attacks and Bypass Surgeries, Kidney Dialysis Processes, Extracorporeal Life Suppo...
$ 3650